Notes to Condensed Consolidated Financial Statements (unaudited)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (the company or Baxter) have been prepared pursuant to
the rules and regulations of the Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been
condensed or omitted. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the companys 2003 Annual Report to Stockholders (2003 Annual
Report).
In the opinion of management, the interim condensed consolidated
financial statements reflect all adjustments necessary for a fair presentation of the interim periods. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim period are not
necessarily indicative of the results of operations to be expected for the full year.
Certain reclassifications have been made to conform the 2003 financial statements and notes to the 2004 presentation.
Stock compensation plans
The company has a number of stock-based employee compensation plans, including stock option, stock purchase and restricted stock plans. The company applies the
recognition and measurement principles of Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations in accounting for these plans. In accordance with this intrinsic value method, no
compensation expense is recognized for the companys fixed stock option plans and employee stock purchase plans. The following table illustrates the effect on net income and earnings per share (EPS) if the company had applied the fair value
recognition provisions of Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based Compensation, to all stock-based employee compensation.
|
|
|
|
|
|
|
|
|
|
|
Restated
|
|
|
|
Three months ended
March 31,
|
|
(in millions, except per share data)
|
|
2004
|
|
2003
|
|
Net income, as reported
|
|
$
|
176
|
|
$
|
214
|
|
Add: Stock-based employee compensation expense included in reported net income, net of tax
|
|
|
|
|
|
|
|
Deduct: Total stock-based employee compensation expense determined under the fair value method, net of tax
|
|
|
28
|
|
|
37
|
|
|
|
|
|
|
|
|
|
Pro forma net income
|
|
$
|
148
|
|
$
|
177
|
|
|
|
|
|
|
|
|
|
Earnings per basic share
|
|
|
|
|
|
|
|
As reported
|
|
$
|
0.29
|
|
$
|
0.36
|
|
Pro forma
|
|
$
|
0.25
|
|
$
|
0.30
|
|
|
|
|
|
|
|
|
|
Earnings per diluted share
|
|
|
|
|
|
|
|
As reported
|
|
$
|
0.28
|
|
$
|
0.35
|
|
Pro forma
|
|
$
|
0.23
|
|
$
|
0.29
|
|
|
|
|
|
|
|
|
5
Changes in accounting principles
Financial Accounting Standards Board (FASB) Interpretation No. 46, Consolidation of Variable Interest Entities (FIN 46) was
adopted July 1, 2003. Refer to the 2003 Annual Report for further information. In December 2003 the FASB revised and reissued FIN 46 (FIN 46-R). The provisions of FIN 46-R were required to be adopted no later than March 31, 2004. Baxter adopted FIN
46-R on March 31, 2004, and adoption of the revised standard did not have a material impact on the companys consolidated financial statements.
1A. RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS
The company has restated its previously issued financial statements for 2001 through 2003 and the first quarter of 2004, primarily the
result of the inappropriate application of accounting principles for revenue recognition and inadequate provisions for bad debts in Brazil during the period. Specifically, the company has restated previously issued financial information for 2001
through 2003 contained in its previously filed Form 10-Ks for the years ended December 31, 2003, 2002 and 2001 by filing a Form 10-K/A for the year ended December 31, 2003. The companys previously reported quarterly information in its Form
10-Qs for the quarters ended March 31, 2004, September 30, 2003, June 30, 2003 and March 31, 2003 have also been restated by filing a Form 10-Q for the quarter ended June 30, 2004 and Form 10-Q/As for the quarters ended March 31, 2004 and September
30, 2003. As a result of the restatement, in aggregate, net sales decreased $37 million (0.2% of the originally reported amount) and net income decreased $33 million (1.5% of the originally reported amount) over the three-year period ended December
31, 2003.
The following is a summary of the impact of the restatement on the
previously issued consolidated income statements and consolidated balance sheets included in this filing. For the first quarter of 2004, net sales were unchanged as a result of the restatement and net income decreased $2 million (1.1% of the
originally reported amount). For the first quarter of 2003, net sales decreased $2 million (0.1% of the originally reported amount) and net income decreased $2 million (0.9% of the originally reported amount).
Consolidated Statements of Income for the Three Months Ended March 31, 2004 and 2003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31,
|
|
|
|
|
2004
|
|
|
2003
|
|
|
(in millions, except per share data)
|
|
As
originally
reported
|
|
|
As
restated
|
|
|
As
originally
reported
|
|
|
As
restated
|
|
|
Net sales
|
|
$2,209
|
|
|
$2,209
|
|
|
$1,997
|
|
|
$1,995
|
|
|
Costs and expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
1,315
|
|
|
1,316
|
|
|
1,117
|
|
|
1,117
|
|
|
Marketing and administrative expenses
|
|
464
|
|
|
466
|
|
|
413
|
|
|
414
|
|
|
Research and development expenses
|
|
136
|
|
|
136
|
|
|
136
|
|
|
136
|
|
|
Net interest expense
|
|
21
|
|
|
21
|
|
|
19
|
|
|
19
|
|
|
Other expense, net
|
|
21
|
|
|
21
|
|
|
26
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses
|
|
1,957
|
|
|
1,960
|
|
|
1,711
|
|
|
1,712
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes
|
|
252
|
|
|
249
|
|
|
286
|
|
|
283
|
|
|
Income tax expense
|
|
63
|
|
|
62
|
|
|
69
|
|
|
68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
189
|
|
|
187
|
|
|
217
|
|
|
215
|
|
|
Discontinued operations
|
|
(11
|
)
|
|
(11
|
)
|
|
(1
|
)
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ 178
|
|
|
$ 176
|
|
|
$ 216
|
|
|
$ 214
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per basic common share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$ 0.31
|
|
|
$ 0.31
|
|
|
$ 0.36
|
|
|
$ 0.36
|
|
|
Discontinued operations
|
|
(0.02
|
)
|
|
(0.02
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ 0.29
|
|
|
$ 0.29
|
|
|
$ 0.36
|
|
|
$ 0.36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per diluted common share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$ 0.31
|
|
|
$ 0.30
|
|
|
$ 0.36
|
|
|
$ 0.36
|
|
|
Discontinued operations
|
|
(0.02
|
)
|
|
(0.02
|
)
|
|
(0.01
|
)
|
|
(0.01
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ 0.29
|
|
|
$ 0.28
|
|
|
$ 0.35
|
|
|
$ 0.35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6